Washington's new export controls on Anthropic's advanced models are backfiring faster than anticipated. The U.S. blocked foreign access to Claude 3.5 Sonnet and other top-tier models four days ago, aiming to preserve America's competitive edge in AI. Instead, the policy is accelerating adoption of competitors worldwide.
Cohere is fielding a surge of government inquiries from countries locked out of Anthropic's technology. DeepSeek just closed a $7.4 billion funding round, the largest ever for a Chinese AI lab. Chinese competitors are slashing token prices up to 99 percent to capture market share from users who suddenly lost access to Anthropic's models.
The policy creates immediate incentives for foreign governments and enterprises to fund domestic alternatives. Rather than creating dependency on U.S. technology, the restriction speeds development and investment in rival systems. Chinese labs now have both capital and motivated customers.
The supply chain vulnerabilities are equally alarming. Security researchers discovered 144 poisoned npm packages inserted into JavaScript repositories. The packages harvest credentials and other sensitive data from AI development pipelines. The attack exploits the rush to integrate third-party libraries in modern AI applications, turning the open-source ecosystem into what amounts to an automated credential theft operation.
These two stories illustrate the core tension in AI governance. Restrictive export controls push innovation and investment offshore while creating security gaps in the domestic supply chain. Companies racing to comply with restrictions often cut corners on security. The poisoned npm packages succeeded because developers prioritize speed over scrutiny when assembling their tech stacks.
The export control strategy assumes isolation works. History suggests otherwise. The semiconductor export restrictions on China drove investment in domestic chip design. These AI controls are likely to follow the same pattern. Foreign labs now have both funding and urgency to build systems that don't depend on U.S. approval.